Nathan Jones, CEO of Xlear, submitted this open letter to the natural products industry "to share Xlear’s experiences with the Federal Trade Commission (FTC) and the Department of Justice (DOJ) and to offer some cautionary advice."
CRN said FTC's guidance misrepresents the state of the law with respect to advertising substantiation for dietary supplements and food. Take a look at the top concerns.
Washington, DC–Before vacating his office on April 5, former FDA Commissioner Scott Gottlieb, M.D., shared his thoughts on the most efficient pathway to legalize CBD. As WholeFoods previously reported, Dr. Gottlieb attended his final hearing before a Senate appropriations subcommittee in March. When questioned about CBD, he stated that the...
Basel, Switzerland—Lonza has announced the adjustment of its Mid-Term Guidance 2022 to reflect the divestment of its former Water Care business unit and to emphasize its focus on growth along the Healthcare Continuum, a press release says. Adjusted guidance is the following, according to the press release: Sales of CHF...
Austin, TX — The American Botanical Council (ABC), American Herbal Pharmacopoeia (AHP), and the University of Mississippi's National Center for Natural Products Research (NCNPR) have a partnership called the Botanical Adulterants Program as a way to spread knowledge among the herbal and dietary supplement industry about best practices regarding product adulteration.
